Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks.
Journal Information
Full Title: J Exp Clin Cancer Res
Abbreviation: J Exp Clin Cancer Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare none. Competing interests The authors declare none."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by the National Institutes of Health (R21 NS093387, P50 CA127001, TL1 TR003169, R61/R33NS111058 and P30 CA016672), by the Cancer Prevention and Research Institute of Texas (DP160014) and by the Department of Defense (W81XWH2110728)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025